Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 1997

View Archived Issues

Sigma-Tau reports therapeutically active seco-D steroid derivatives

New dopamine receptor ligands reported by Roche

Takeda discloses lankacidin derivatives

Anticancer/antimetastatic agents from Sankyo

Japanese investigators isolate novel aminopeptidase inhibitor

Novel antioxidant disclosed by Nippon Chemiphar

Terumo prepares smooth muscle cell proliferation inhibitors

Hypoglycemic agents from Nippon Chemiphar

Therapeutically active glycomimetic saccharopeptides from Glycomed

Merck & Co. claims FPTase inhibitors for cancer

Immunotherapeutic vaccine for CML reported in patent literature

Pfizer investigates beta-adrenoceptor agonists

Pfizer reports new GH stimulants

Isis and UCSF awarded grant for combinatorial drug discovery

Company Profile: Advanced Plant Pharmaceuticals

Company Profile: Structural Bioinformatics

Company Profile: Cortex

Cortecs signs first European licensing agreement for oral calcitonin

Tularik, Merck & Co. extend R&D agreement

Antisense mechanism of Isis/Ciba compound demonstrated

SnET2 trials now span three continents

Panax acquires colon-clearing drug for colonoscopy preparation

CPMP approves unified labeling for Intron A

Gensia stockholders to vote on proposed acquisitions

Terrapin, Sanwa establish diabetes R&D collaboration

AutoImmune updates clinical program for oral RA product

AI-401 clinical trial program updated

MacroChem to begin clinical trials of SEPA-testosterone

New treatment option for HIV-infected children

AltaRex's lead product given orphan drug status

Neovastat enters clinic in the U.S.

Obstacles to tolerance induction in the treatment of autoimmune disease

Medarex forms European subsidiary and research alliance

Name change for Anika

Techniclone seeks to control Peregrine

Conclusion of Cephalon/Schering-Plough AD collaboration

New tumor immunotherapy approach described by U.S. academic researchers

Hybridon to begin French clinical trials on anti-CMV antisense compound

IDEC licenses technology to Boehringer Ingelheim

FDA approves topical acne treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...